Iosif Strouthos
Overview
Explore the profile of Iosif Strouthos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hausmann P, Zschaeck S, Furth C, Nikulin P, Cegla P, Roohani S, et al.
J Nucl Med
. 2025 Mar;
PMID: 40081960
Tumor asphericity in F-FDG PET is a prognostic marker that has been investigated in small pilot studies of patients with head and neck squamous cell carcinoma (HNSCC). Here, we investigated...
2.
Zschaeck S, Hajiyianni M, Hausmann P, Nikulin P, Kukuk E, Furth C, et al.
Cancer Imaging
. 2025 Feb;
25(1):18.
PMID: 39985091
Background: Oropharyngeal carcinomas are characterized by an increasing incidence and a relatively good prognosis. Nonetheless, a considerable number of patients develops metachronous distant metastases; identification of these patients is an...
3.
Roussakis Y, Antorkas G, Georgiou L, Strouthos I, Karagiannis E, Zamboglou C, et al.
J Contemp Brachytherapy
. 2024 Dec;
16(3):211-218.
PMID: 39629089
Purpose: The aim of this study was a retrospective dosimetric comparison of iridium-192 (Ir) high-dose-rate (HDR) interstitial brachytherapy plans using model-based dose calculation algorithm (MBDCA) following TG-186 recommendations and TG-43...
4.
Zamboglou C, Staus P, Wolkewitz M, Peeken J, Ferentinos K, Strouthos I, et al.
Eur Urol Focus
. 2024 Nov;
PMID: 39609244
Background And Objective: Up to 50% of patients with prostate cancer experience prostate-specific antigen (PSA) relapse following primary radical prostatectomy (RP). Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) is...
5.
Hadjicharalambous M, Roussakis Y, Bourantas G, Ioannou E, Miller K, Doolan P, et al.
Front Physiol
. 2024 Nov;
15:1491144.
PMID: 39512470
High dose-rate brachytherapy presents a promising therapeutic avenue for prostate cancer management, involving the temporary implantation of catheters which deliver radioactive sources to the cancerous site. However, as catheters puncture...
6.
Voutouri C, Englezos D, Zamboglou C, Strouthos I, Papanastasiou G, Stylianopoulos T
Commun Med (Lond)
. 2024 Oct;
4(1):203.
PMID: 39420199
Background: In the era of personalized cancer treatment, understanding the intrinsic heterogeneity of tumors is crucial. Despite some patients responding favorably to a particular treatment, others may not benefit, leading...
7.
Nearchou M, Georgiou E, Vrachimis A, Ferentinos K, Strouthos I
Front Nucl Med
. 2024 Oct;
3:1319952.
PMID: 39355050
Background: 18F-prostate specific membrane antigen (PSMA) PET is fast becoming the gold-standard in prostate cancer, both in staging of intermediate-/high-risk patients and in re-staging patients with biochemical failure. Several pitfalls...
8.
Janbain A, Farolfi A, Guenegou-Arnoux A, Romengas L, Scharl S, Fanti S, et al.
JMIR Cancer
. 2024 Sep;
10:e60323.
PMID: 39303279
Background: Salvage radiation therapy (sRT) is often the sole curative option in patients with biochemical recurrence after radical prostatectomy. After sRT, we developed and validated a nomogram to predict freedom...
9.
Photiou C, Cloconi C, Strouthos I
J Imaging Inform Med
. 2024 Sep;
PMID: 39231883
Acute radiation dermatitis (ARD) is a common and distressing issue for cancer patients undergoing radiation therapy, leading to significant morbidity. Despite available treatments, ARD remains a distressing issue, necessitating further...
10.
Trapp C, Aebersold D, Belka C, Casuscelli J, Emmett L, Eze C, et al.
Eur J Nucl Med Mol Imaging
. 2024 Jun;
51(12):3770-3781.
PMID: 38940843
Purpose: Despite growing evidence for bilateral pelvic radiotherapy (whole pelvis RT, WPRT) there is almost no data on unilateral RT (hemi pelvis RT, HPRT) in patients with nodal recurrent prostate...